Twitter debate: controversies in functional gastrointestinal disorders.
作者信息
Maurice James, Widlak Monika M, Emmanuel Anton V
机构信息
Deparment of Hepatology, Imperial College, London, UK.
Department of Gastroenterology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
出版信息
Frontline Gastroenterol. 2019 Jul 19;11(3):249-251. doi: 10.1136/flgastro-2019-101246. eCollection 2020.
Abstract
The new 'Controversies In…' series for the Frontline Gastroenterology Twitter debates addressed the difficult area of functional gastrointestinal disorders, facilitated by the former editor-in-chief Anton Emmanuel. Key topics discussed included distinguishing functional dyspepsia from genuine gastroparesis, when we should investigate for bile acid malabsorption, the current treatments for constipation-predominant irritable bowel syndrome and, importantly, how to manage consultations with complex patients presenting with functional bowel disease. The debate generated over a million impressions on twitter and this article aims to summarise the key educational points from the event.
摘要
相似文献
1
Twitter debate: controversies in functional gastrointestinal disorders.
Frontline Gastroenterol. 2019 Jul 19;11(3):249-251. doi: 10.1136/flgastro-2019-101246. eCollection 2020.
2
Twitter debate: controversies in the management of portal hypertension.推特辩论：门静脉高压管理中的争议
Frontline Gastroenterol. 2020 Jan 30;12(1):77-79. doi: 10.1136/flgastro-2019-101400. eCollection 2021.
3
[Motility and functional gastrointestinal disorders].[运动功能与功能性胃肠疾病]
Gastroenterol Hepatol. 2014 Sep;37 Suppl 3:3-13. doi: 10.1016/S0210-5705(14)70078-0.
4
Functional and motor gastrointestinal disorders.功能性和运动性胃肠疾病
Gastroenterol Hepatol. 2016 Sep;39 Suppl 1:3-13. doi: 10.1016/S0210-5705(16)30169-8.
5
[Functional and motor gastrointestinal disorders].[功能性和运动性胃肠疾病]
Gastroenterol Hepatol. 2015 Sep;38 Suppl 1:3-12. doi: 10.1016/S0210-5705(15)30014-5.
6
Prokinetics in the Management of Functional Gastrointestinal Disorders.促动力药在功能性胃肠病管理中的应用
Curr Gastroenterol Rep. 2017 Sep 8;19(10):53. doi: 10.1007/s11894-017-0593-6.
7
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome.非溃疡性消化不良和肠易激综合征中人格与症状之间的关系。
Gastroenterology. 1990 Aug;99(2):327-33. doi: 10.1016/0016-5085(90)91012-u.
8
[Functional and motility gastrointestinal disorders].[功能性胃肠动力障碍]
Gastroenterol Hepatol. 2012 Sep;35 Suppl 1:3-11. doi: 10.1016/S0210-5705(12)70029-8.
9
Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders?综述文章：功能性消化不良与肠易激综合征的重叠——一种还是两种疾病？
Aliment Pharmacol Ther. 2004 Nov;20 Suppl 7:40-9. doi: 10.1111/j.1365-2036.2004.02184.x.
10
[Functional and motility gastrointestinal disorders].[功能性胃肠动力障碍]
Gastroenterol Hepatol. 2011 Oct;34 Suppl 2:3-14. doi: 10.1016/S0210-5705(11)70016-4.
本文引用的文献
1
Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol.胃肠聚焦催眠治疗功能性胃肠疾病：循证、实践要点和曼彻斯特方案。
Neurogastroenterol Motil. 2019 Aug;31(8):e13573. doi: 10.1111/nmo.13573. Epub 2019 Feb 27.
2
Intending to Treat Patients With Irritable Bowel Syndrome With Cognitive-Behavioral Therapy.
Gastroenterology. 2018 Dec;155(6):2024. doi: 10.1053/j.gastro.2018.05.054. Epub 2018 Sep 18.
3
Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.促分泌剂治疗便秘型肠易激综合征的疗效：系统评价和网络荟萃分析。
Gastroenterology. 2018 Dec;155(6):1753-1763. doi: 10.1053/j.gastro.2018.08.021. Epub 2018 Aug 23.
4
Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.粪便微生物群移植改变肠易激综合征患者的肠道微生物群：一项随机、双盲、安慰剂对照研究的结果。
Gut. 2018 Dec;67(12):2107-2115. doi: 10.1136/gutjnl-2018-316434. Epub 2018 Jul 6.
5
Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.功能性胃肠病的神经调节剂（肠脑相互作用障碍）：罗马基金会工作组报告。
Gastroenterology. 2018 Mar;154(4):1140-1171.e1. doi: 10.1053/j.gastro.2017.11.279. Epub 2017 Dec 22.
6
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.粪便微生物群移植与安慰剂治疗中重度肠易激综合征的随机双盲对照平行分组单中心试验。
Lancet Gastroenterol Hepatol. 2018 Jan;3(1):17-24. doi: 10.1016/S2468-1253(17)30338-2. Epub 2017 Nov 1.
7
Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.可发酵短链碳水化合物饮食含量变化对肠易激综合征患者症状、粪便微环境及细胞因子谱的影响
Neurogastroenterol Motil. 2017 Apr;29(4). doi: 10.1111/nmo.12969. Epub 2016 Oct 16.
8
A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D).一项关于美沙拉嗪治疗腹泻型肠易激综合征（IBS-D）的多中心、平行组、随机安慰剂对照机制性试验。
Gut. 2016 Jan;65(1):91-9. doi: 10.1136/gutjnl-2015-309122. Epub 2015 Mar 12.
9
Randomised controlled trial of mesalazine in IBS.美沙拉嗪治疗肠易激综合征的随机对照试验。
Gut. 2016 Jan;65(1):82-90. doi: 10.1136/gutjnl-2014-308188. Epub 2014 Dec 22.
10
Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.抗抑郁药和心理疗法，包括催眠疗法，对肠易激综合征的疗效：系统评价和荟萃分析。
Am J Gastroenterol. 2014 Sep;109(9):1350-65; quiz 1366. doi: 10.1038/ajg.2014.148. Epub 2014 Jun 17.
Zotero 插件